Linked Life Data

1662279

Source:http://linkedlifedata.com/resource/pubmed/id/1662279

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
1992-2-7
pubmed:abstractText
We examined the effects of a new ligand, FPLnM-64176, on L-type Ca++ channels in cardiac tissue. FPL 64176 (10-1 microM) enhanced Ca++ influx into neonatal rat ventricular myocytes, a response which was blocked by nifedipine. FPL 64176 had no effect on [3H]PN200-110 binding in rat ventricular membranes, but dramatically increased L-type Ca++ channel current amplitude. FPL 64176 (1 microM) slowed both the activation and the inactivation kinetics of the L-channel in neonatal rat ventricular cells. We also noted a hyperpolarizing shift in the threshold and peak potential of the Ca++ channel current-voltage relationship in response to the compound. Additionally, the binding site for FPL 64176 appeared to be located on the extracellular face of the channel. We conclude that FPL 64176 is a potent new activator of L-type Ca++ channels with a novel mechanism and site of action.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
0022-3565
pubmed:author
pubmed:issnType
Print
pubmed:volume
259
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
982-7
pubmed:dateRevised
2008-11-21
pubmed:meshHeading
pubmed:year
1991
pubmed:articleTitle
A new site for the activation of cardiac calcium channels defined by the nondihydropyridine FPL 64176.
pubmed:affiliation
Marion Merrell Dow Research Institute, Cincinnati, Ohio.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S., Research Support, Non-U.S. Gov't